Megan R. Haymart, Mousumi Banerjee, Di Yang, Andrew K. Stewart, Ronald J. Koenig and Jennifer J. Griggs The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer Cancer 119
Article first published online: 28 JUN 2012 | DOI: 10.1002/cncr.27721
There is heterogeneity in clinician decision making for the management of patients with thyroid cancer. The specialty of the primary decision maker, the number of providers administering radioactive iodine, and access to a tumor board are associated significantly with the use of radioactive iodine for stage I thyroid cancer.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field